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Chapter 23 
Reorganising Chronic Disease Management: Diabetes and 
Bureaucratic Technologies in Post-War British General Practice 
 
Martin D. Moore 
 
On 1 April 1990, the third Thatcher administration imposed a new contract upon 
British general practitioners (GPs). As part of its plans to remake both the National 
Health Service (NHS) and UK public health, the Conservative Government made 
available to GPs for the first time specific remuneration for undertaking special health 
promotion clinics - a service which covered a range of chronic conditions and their risk 
factors.1 By 1993, subsequent Conservative governments had introduced distinct 
incentives for `chronic disease management’ clinics, issued protocol to outline process 
measures required for chronic disease payments, and incorporated a number of chronic 
diseases in new target-based public health programmes.2 
Taken together, these initiatives marked the first major and sustained policy 
concern with `chronic disease’ at the central government level in Britain. As recent 
work has shown, of course, this was not the first time that policy-makers had 
demonstrated an interest in long-term sickness or in specific chronic conditions.3 The 
care of the `chronic sick’, populations of largely elderly and infirm patients 
institutionalised in Britain’s hospitals, had been a service concern since at least the 
1940s.4 The GP policies were, nonetheless, the first time that the Department of Health 
had based the reform of services around chronic disease as a distinct - if elastic - 
category and object of policy. It was a trend, George Weisz makes clear, which gained a 
contested momentum over the 2000s, in line with various international developments.5 
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Below the level of central government policy, however, concepts of chronic 
disease - and the organisational challenges of long-term care - had been influential in 
encouraging reform of local services for decades prior to these changes. New models for 
chronic disease care based in general practice, though often closely integrated with 
hospital clinics, had first emerged in the early 1970s, and began to spread widely during 
the 1980s. In diabetes, the new systems of care were predicated upon proactive disease 
surveillance of `routine’ patients in community settings, with specialist hospital 
outpatient clinics reserved for consultation or more `complicated’ cases. GPs slowly 
assumed the position of the head of the `primary care health team’, having direct access 
to nursing, ancillary and clerical staff. Finally, the whole system was facilitated by the 
deployment of numerous forms of managerial bureaucratic instruments, ranging from 
patient register and appointment systems (allowing the management of time and 
attendance), to codified treatment protocol and mobile clinical records (directing labour 
and facilitating shared data storage and retrieval).6 Similar developments not only 
occurred in relation to hypertension and asthma during the same decades, but clinicians 
also consciously drew upon experiences across conditions.7 Shared `natural histories’, 
intellectual networks, and sites of care facilitated the exchange of organisational and 
bureaucratic technologies.8 
Using a case study of non-insulin-dependent diabetes mellitus, this chapter 
examines the emergence of this disease management model in post-war Britain. Whilst 
recognising the influence of shifting epidemiological patterns, it nonetheless situates 
developments in relation to resource constraints, professional politics, and innovations 
in medical knowledge and technology. In the face of stagnant resources, consultants felt 
that diabetes care was no longer sustainable as a solely hospital specialty, especially as 
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changing diagnostic and therapeutic patterns transformed the character of both disease 
and specialty clinic. The proposed solution of moving greater patient care to - and 
systematising patient management in - general practice was only accepted nationally 
because it fitted political and ideological projects of general practice reform. By the 
1980s, discussions of diabetes care – and its proactive and bureaucratised surveillance 
of risk - increasingly mapped onto broader considerations of modern general practice. 
And by 1990, new models of GP care received formal political backing. 
In telling this story, this chapter seeks to provide insight into the adaptation of 
British health services - and general practice in particular - to the challenges of chronic 
disease after the Second World War. Whilst historians have produced excellent studies 
of how public health ideology and central government policy engaged with chronic 
disease in the post-war period, little has been written in this regard about service 
innovation.9 Similarly, although there are numerous accounts detailing the political and 
institutional histories of the NHS, its scholars have largely neglected the study of post-
war general practice and the emergence of new models of care outside of key policy 
years.10  Diabetes mellitus provides an effective case study for many of the key 
developments in post-war service changes in relation to chronic disease. This is not 
because of any essential features of the disease itself, but rather because doctors 
discussed approaches to diabetes management as models for other conditions.11 
Moreover, as diabetes care became embedded within visions for reforming general 
practice more broadly, its study also opens a vista onto the broader transformation of 
general practice as a distinct form of medicine.  
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Diabetes and hospital management 
By the early 1950s, diabetes was considered a metabolic disorder or syndrome, 
primarily caused by a deficiency of, or insensitivity to, insulin.12 The cardinal markers 
for the disturbance were taken to be high levels of glucose in the blood 
(hyperglycaemia) and urine (glycosuria), whilst clinicians had described a range of 
prominent symptoms in relation to the condition (including excessive urination, thirst 
and hunger) across a number of centuries.13 Since the 1930s, doctors had also noted 
patients with diabetes developing a plethora of renal, micro- and macro-vascular 
`complications’ over time, so that by the 1950s major concerns existed about 
neuropathy, nephropathy and retinopathy in patients as much as their liability to various 
types of coma.14  
It was in relation to coma, along with age of onset and weight, that clinicians 
roughly `typed’ patients from the 1920s onwards. That is, while researchers had posited 
various causes for (and exceptions to) such a division, doctors tended to discuss patients 
as either ‘severe’ - typically young and thin at onset, and needing insulin to prevent 
rapid hyperglycaemia, wasting and ketosis - or ‘mild’ - individuals who were largely 
overweight and above 45 years old at onset, but who were able to maintain normal 
metabolic function through various forms of diet alone.15 Alternative terms for dividing 
patients existed over the post-war period – for instance, `juvenile’ and `maturity-onset’ 
diabetes, and later ‘insulin-dependent diabetes mellitus’ and ‘non insulin-dependent 
diabetes mellitus’ – but in essence it was a patient’s symptoms, ketones, and response to 
treatment that determined clinical course and categorisation.16 The development of oral 
hypoglycaemic drugs during the 1950s further consolidated therapeutic and clinical 
divisions, proving efficacious in only certain classes of supposedly `mild’ patients.17 
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It was in relation to the clinically more challenging severe patients that specialist 
clinics had been developed in Britain after the introduction of insulin therapy in 1922.18 
On the one hand, clinics were praised for their research and teaching potential, and the 
invention of insulin therapy helped generate the financial and cultural capital necessary 
for institutionalising specialist research and practice.19 On the other, interested doctors 
justified these clinics into the 1940s and 1950s by suggesting that their concentration of 
expertise and laboratory facilities were central to maintaining patient health.20 Such 
claims recognised that management of diabetes had come to centre on long-term 
monitoring of various metabolic and clinical markers of disease progression, despite the 
growth of significant doubts about the long-term benefits of ‘normoglycaemic’ control 
over previous decades.21 And clinics, at least initially, were designed to facilitate more 
organised access to the required laboratory facilities for surveillance, as well as to offer 
ongoing consultation and education for patients in their self-management.22 
Although GPs continued to offer varying levels of care, by the 1950s hospital 
clinics had been widely - if reluctantly - accepted as the ideal place for long-term and 
specialist surveillance of patients with diabetes.23 GPs and hospital clinicians alike 
noted how ‘diabetes mellitus…and its management is gradually being taken out of the 
hands of the general practitioner by the establishment of diabetic clinics’, a trend that 
even resentful GPs described as a ‘relief’ in terms of workload.24 Such observations find 
support in the rapidly increasing numbers of clinics through the 1940s and 1950s, rising 
from 40 clinics in 1940 to 194 in 1955.25 The importance of clinics and specialist 
supervision received recognition from the Ministry of Health, which issued guidance on 
the regional organisation of in-patient and out-patient services in 1953.26 
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The 1950s, however, in many ways marked the zenith of the clinic’s reputation. 
Over the following decade and a half, doctors began to note a number of problems with 
clinic practice. Whereas doctors had previously lauded the clinic’s concentration of 
patients, many clinicians now voiced concerns about the strains that such centralisation 
placed on care as patient numbers grew. At one major centre in the Leicester Royal 
Infirmary (LRI), for instance, registered attendances rose from 6379 in 1949 to 9854 in 
1965.27 It was in response to similar growth that John Malins, an eminent mid-century 
authority in the famous Birmingham clinic, suggested that: ‘the size of the diabetic 
problem…is apt to oust all other work unless the intake of patients is strictly controlled 
- no easy matter’, and ‘as a result the clinic is apt to become large and unwieldy’.28 In 
part, such increases may have resulted from patients living longer in line with new 
therapies and improved facilities.29 However, greater detection and referral from general 
practice also played a role, with the average number of new patient attendances yearly at 
the LRI increasing over 60 per cent from 286 for 1949-52 to 483 for 1959-62.30  
During the 1950s and 1960s, clinical and public health doctors identified a range 
of factors supposedly responsible for the increase in the incidence and prevalence of 
diabetes. They implicated more sedentary lifestyles, rising affluence, rapidly altered 
diets, the `conquest’ of infectious disease, and a general ageing of the population as 
potential causes.31 Such explanatory frameworks formed part of wider concerns with 
reframing public health in terms of both chronic disease and lifestyle change, a 
development itself intimately tied to the creation of the new tools of risk factor 
epidemiology.32 Increases in clinic patient load also had some relation to the 
development of new diagnostic technologies, with two innovations in particular worthy 
of mention. The first was a new heat-producing tablet, available from 1944, which 
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removed the need for doctors to measure solutions and heat urine for testing.33 The 
second, a variety of enzyme-loaded paper, was developed in the 1950s and allowed 
practitioners to identify initial glycosuria by the strip changing colour when dipped in a 
urine sample.34 Although each took time to become widely available to GPs, both 
nonetheless made initial detection of diabetes considerably easier, with one trial even 
suggesting that tablets more than halved testing times.35  
The enzyme-loaded strips in particular were central to a wave of major diabetes 
population surveys taking place in Britain between the early 1950s and mid-1960s, with 
substantial effects on awareness and understandings of diabetes. The surveys had an 
international impetus. Many were inspired by equivalent American undertakings in the 
1940s, and they later formed part of efforts to assess global prevalence through research 
networks established as part of colonial expansion.36 They reflected, nonetheless, a 
growing interest in epidemiological surveys of chronic disease in Britain, and were 
underpinned by the significant growth of post-war finance for biomedical research.37 In 
the short term these surveys were designed to assess the extent of unmet need for 
health-care services, and to hint at potential physiological precursors or socio-cultural 
causes to be longitudinally assessed.38 With regards to diabetes, they uncovered 
significant numbers of undiagnosed cases to add to local clinics, roughly doubling the 
number of patients in any given community.39 In the longer term, increased numbers 
were likely compounded by raised professional and public awareness. In the national 
press, specialists increased estimates of national prevalence from between 3 and 6 cases 
per thousand population in 1950, to around 12 per thousand by 1960, and the potential 
existence of significant amounts of hidden disease was widely reported.40 National 
figures, along with the novel notion of submerged disease, concerned the profession and 
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were repeated in the press. The subject of diabetes detection also featured more 
prominently at national medical conferences and in major medical journals, including 
one exchange in The Lancet during 1963 taking in seven letters over six editions and 
three months.41 
Unfortunately for hospital doctors, the rising numbers of patients under their 
care were not matched by increasing finances. Resources under the new National Health 
Service were scarce and under intense political scrutiny.42 Initial projections for 
resource requirements had been wildly inaccurate, and the resulting disconnect with 
actual spending frightened politicians into introducing new rationing measures and 
subjecting the Service to consistent financial review.43 Whilst the most politically 
significant investigation into NHS expenditure during this decade - the Guillebaud 
Report (1956) - defended the NHS as excellent value for money, searches for savings in 
resource use intensified over subsequent decades.44 By the 1960s, this scrutiny had 
turned to a search for improved management of expensive hospital facilities, with 
voluntary health organisations and central government alike examining means for better 
organisation of resources and outpatient clinics.45 Under such circumstances, the 
retention of large numbers of patients under specialist care became both financially 
challenging and politically problematic. Concern with overcrowding in outpatients 
departments peaked in the early 1970s, and led The Lancet to blame consultants for 
confusing quantity with quality in assessing their worth, and for undertaking work 
which was ‘quite unnecessary’.46 
In the face of this combination of rising patient numbers and strained resources, 
clinicians became increasingly dissatisfied with both standards offered to patients and 
the conditions of their work. Initial attempts to compensate for changed conditions 
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involved drafting in more junior staff to assist. However, their characteristically short 
tenures broke the continuity of care that long underpinned the logic of clinics.47 Equally, 
the drive for efficiency in terms of patient turnover left practitioners disgruntled, and 
they claimed that ‘the aims of treatment were becoming increasingly frustrated’ in light 
of resultant ‘overcrowding’.48  
Hospital clinicians also grew tired of the more ‘routine’ patient being seen. 
These tended to be patients on diet alone or oral drugs, with physicians complaining that 
their ‘management is not difficult and they would have been discharged to their general 
practitioner if it was known they would have regular supervision of their diabetes in the 
practice’.49 This tilting towards the predominance of `mild’ patients had been noted in 
the early 1950s, but was possibly accelerated by the application of the survey and its 
mutation of diabetes into a less symptomatic and more quantitative disease entity.50 
Physiological research, that is, had long shown that there was no single norm for 
average blood glucose levels in humans, and even during the 1920s and 1930s, models 
of diabetes had suggested that clinical symptoms appeared often only after a long 
asymptomatic onset.51 However, along with uncovering `hidden’ cases of clear diabetes, 
new surveys suggested that far more people experienced blood glucose levels outside a 
clearly-bounded `normal range’ than had been expected.52 The meaning of these 
quantitative deviations was unclear, correlating neither with symptoms, clear lesions, 
nor a definite increased likelihood of pathological change in the future.53 Indeed, whilst 
some patients with `abnormal’ results might go on to develop symptomatic diabetes, 
when retested a number might revert to `normal’ tolerance.54  
When found in individuals, these ‘borderline’ results left clinicians unclear as to 
what level of hyperglycaemia could be considered pathological, especially in older age 
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groups where glucose tolerance appeared to decline.55 Conceptually borrowing from 
hypertension, some clinicians and researchers in the mid-1960s even wondered whether 
‘benign and malignant hyperglycaemia would be preferable terms’ to diabetes.56 By 
1980, follow-up studies of the relationship between persistent hyperglycaemia and 
complications in populations would fix diagnostic criteria for individuals in relation to 
quantitative risk for diabetic retinopathy.57 In the meantime, however, it is possible that 
this changed character of disease and diagnostic uncertainty led to even more `mild’ 
hyperglycaemic patients appearing in clinics, even if symptoms continued to form the 
major prompt for diagnosis into the 1970s.58 With such patients more common than 
before, specialists complained that they were unable to focus on the ‘difficult problems’ 
suited to their training.59 Experience, efficiency drives and an expanded disease concept 
had turned diabetes into a routine disease; such a change frustrated hospital doctors who 
felt such patients less requiring of their skills than others. 
 
New models of care and bureaucratic tools in general practice 
By the late 1960s and early 1970s, a number of hospital consultants and diabetes 
specialists had decided that easing the pressures on clinics would require more radical 
solutions than tried previously, primarily involving moving patients out of the clinics. 
At the same, there were GPs who felt that standards in general practice could also be 
improved through better organisation and co-operation, particularly where GP 
responsibility for patients had been retained.60 Through such drives for reform, diabetes 
care underwent significant change during the following decades. 
In terms of clinics, during the 1970s and 1980s physicians tried a number of 
systems to relieve patient-load, and to extend advice and educational facilities outside of 
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clinic hours.61 The most widely pursued innovation in care during this period was that 
of GPs assuming greater responsibility for the care of routine patients, and those 
deemed well-managed on insulin. In most instances, the initial step in establishing new 
forms of care came from consultants reaching out to GPs. Programmes for GP 
education and care protocol thus developed out of friendly collaboration with GPs.62 
Where such cordiality did not exist, however, hospital-led schemes might meet 
resistance from local practitioners and it was here that specialist nurses were essential, 
building relationships and refining schemes in situations where tensions existed.63 As 
with other forms of service innovation, local politics and culture were clearly important 
in influencing outcomes and trajectories at a micro-level.64 
The form of scheme that GPs and consultants entered into varied according to 
these local circumstances, and could involve multiple practices joining with a clinic in a 
large scheme, or establishing individual relations between consultant and GP in smaller 
ones.65 Likewise, the organisation of GP-care itself also differed across practices. Some 
practitioners sought to run special `mini-clinics’ in protected surgery time, headed by 
one or two interested GPs if operating within a group surgery. Here, patients were 
registered and recalled for regular follow-up consultations and tested at their local 
practice in a single sitting. Nursing staff would undertake patient education and take 
samples, whilst GPs performed more complex screening procedures, analysed results 
and offered advice. Patients were generally requested to attend at intervals of three to six 
months for at least glucose, ketone, weight, and visual acuity tests, with a special check-
up - including screening for complications – performed annually.66 A mixture of 
automated testing equipment and contractual arrangements for direct access to off-site 
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diagnostic facilities fostered independence, though some mini-clinics directly involved 
hospital staff.67 
Other schemes, by contrast, encouraged all GPs to look after their own listed 
patients. Here, the routine surveillance of patients would be undertaken during regular 
surgery time and the link between patient and single practitioner would not be broken. 
In perhaps the most comprehensive of these shared care schemes, established in Poole 
during the early 1970s, some patients had no direct contact with the hospital, except for 
visits to the laboratory for glucose estimations. The rest of the surveillance tests and 
consultation were performed in surgery time, albeit with connections maintained to 
community opticians, whilst community nurses and health visitors were also attached to 
surgeries for domestic visiting and dietetic advice. Technological innovation made 
possible new forms of team work - with communication between care sites achieved via 
computer, as well as letters and patient-held records - whilst all practitioners in the 
scheme signed up to shared care protocol that detailed responsibilities, referral criteria, 
and the aims and metabolic targets of therapy.68 Similar models were tried elsewhere, 
but GPs were able to organise their practice idiosyncratically so long as minimum 
standards of care were agreed and shared records were completed.69 
As time passed a number of other alternatives were created, such as travelling 
clinics for more remote communities, and diabetic days or hours in certain London 
surgeries.70 Learning about these innovations through publication, education, or 
participation in professional conferences, some GPs sought to raise their own standards 
of care for diabetes patients, and had adopted some of these organisational forms 
independently of clinics.71 Although more isolated from clinic teams, some GPs might 
still maintain access to hospital or health authority expertise, such as dietetic advice or 
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chiropody care.72 Along with practice nursing and secretarial staff, that is, some GPs 
operated as the head of a health-care team with referral as an option for more specialist 
services. 
Central to new forms of GP-based care were a series of tools designed to make 
surveillance of the patient population more effective, and to monitor and reform 
professional activity. Common to almost all shared and structured general practice care 
programmes, for instance, were patient registers to help track the size of the observed 
population, and recall systems – buttressed by home visits to non-attenders - to ensure 
regularity and frequency of patient attendance.73 Similarly, advocates of these schemes 
recommended the use of highly structured patient records, generally comprised of a 
checklist of tests to be undertaken, a follow-up section for results to be recorded, and 
additional spaces to record treatment notes and patient information.74 These specially 
designed cards would allow for ‘quick accurate recording and recall of information’, 
thus making it easier to account for a patient’s progress and facilitate communication 
between staff members and over time.75 Moreover, along with the agreed practice 
protocol, designers of these records believed that they would improve the standard of 
care, directing professional action and providing ‘built in reminders so that both patient 
and professional will remember to carry out all the routine and sometimes tedious 
checks which are part and parcel of good diabetic care’.76 As well as helping to review 
the care of individual patients, these records therefore facilitated the shift of surveillance 
onto practitioners. Practice protocol set team responsibilities and ‘the basic standard for 
general practitioner and hospital care’, whilst records were considered key to providing 
the raw material for regular and research-based audits.77 This was so much so that the 
quality of record completion was a prominent audit measure or discussion point in 
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research assessments of GP care.78 Although such highly structured, reviewed and 
bureaucratised care might be thought of as anathema to professionals who so frequently 
spoke of clinical autonomy, as discussed below, this organisation of care was 
constructed as one of the major benefits to systematic general practice involvement in 
diabetes management. 
The extent of GP engagement in structured independent, shared or community 
diabetes management during subsequent years is hard to uncover. From archival 
material and publications it appears that GP-based care had spread right across Britain 
by 1990, with references to practice in: Kirkcaldy and Stirling in Scotland;79 
Newcastle,80 Manchester,81 and Sheffield in the north of England;82 Wolverhampton,83 
parts of Staffordshire,84 Birmingham and Warwickshire,85 Ilkeston,86 Leicester,87 
Nuneaton,88 and parts of Oxfordshire in the English midlands;89 Norwich,90 Kings 
Lynn,91 Newmarket,92 and Ipswich, in the east of England;93 London,94 Southampton,95 
and parts of Surrey and Hampshire in the south of England;96 Poole,97 Bristol,98 and 
Exeter in the South West;99 and Cardiff,100 the Upper Afan Valley,101 Powys and Gwent 
in Wales.102 Thus, whilst initial experiments appeared in the English midlands in 
relation to expertise in the Birmingham area, by the early 1990s shared and structured 
care in general practice had spread widely - if not necessarily deeply - beyond this base. 
 
Diabetes and general practice management 
Why did GPs want to take on such care? And what does the spread of GP-based 
diabetes management tell us about the changing basis of post-war general practice? Of 
course, like hospital clinicians, the authors of early texts about general practice diabetes 
care believed that GP involvement would raise standards, and certainly make care more 
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convenient for patients. These doctors pointed to the inefficiency and depersonalisation 
of ‘the diabetic clinic scrummage’, highlighting its fleeting consultations, costs to 
patients, and broken continuity of care.103 They deemed general practice care, by 
contrast, to be far more amenable to patients, who would have shorter waiting times and 
greater ‘comfort’.104 Familiarity with medical teams, proponents suggested, would also 
make oversight more regular, and thus more effective.105 And indeed, the willingness of 
patients to accept greater GP involvement was itself important in helping new schemes 
gain momentum. 
Yet, these same texts frequently included references to a number of advantages 
for GPs themselves, highlighting a clear political and professional interest in clinical 
change. For instance, initially - and somewhat ironically given references to `routine’ 
patients - hospital doctors and GPs pointed to the intellectual satisfaction gained from 
looking after patients with diabetes. Diabetes was portrayed as a complex condition, 
affecting almost every bodily system, which would provide a ‘wide spectrum of 
experience in symptomatology, pathology and treatment’.106 It was, according to its 
proponents, ‘the ideal disease for the general practitioner to diagnose, observe and treat 
with interest’.107 Diabetes thus sat in opposition to the supposed wave of ‘trivial’ cases 
that some felt characterised general practice, and which even resulted in feelings of 
‘professional humiliation’ over ‘wasted’ training.108 Although such feelings were not 
universal, strong references to work satisfaction and clinical complexity clearly sought 
to make capital from anxieties of inferiority and dissatisfaction, even whilst other 
doctors were trying to rehabilitate such trivia as central to primary care.109 
Discursive appeals to GP interests were multivalent and it was perhaps their 
eclecticism that proved persuasive. Whilst at once emphasising skill, early proponents 
   
 
17 
of GP care also pointed to the need to care for the whole patient in such an ‘all 
embracing condition’.110 GPs knew about the intimate aspects of their patients’ lives, 
and diabetes’ status as a ‘lifelong disease’ combining ‘symptoms and physical and 
biochemical findings with social and emotional problems’ was therefore considered to 
strongly ‘interest the general practitioner’.111 Although managing social and emotional 
problems was clearly seen as a `skill’ – and by the 1950s a skill seen as an integral part 
of diabetic clinic care – it was not one necessarily associated with the hospital form of 
clinical medicine.112 Such references were, therefore, likely alluding to the `whole 
person’ rhetoric associated with views that GPs might become specialists in the psycho-
social medicine of individuals.113 
As time passed, the basis of these claims transformed in line with shifting 
politics of, and visions for, general practice. Alongside references to patient satisfaction 
and improving clinical skill, some advocates for general practice care in the 1970s and 
1980s began to cast diabetes as a model of proactive, preventive medicine. For example, 
one GP suggested that, though ‘extra time is needed to run a clinic’, their team felt ‘that 
diabetics are such a high-risk group tha[t] an average of five minutes per day for 
prevention and treatment is an efficient use of a doctor’s time’.114 Another 
retrospectively agreed, suggesting that the programme for diabetes in his practice 
emerged due not only to ‘an impression that we could do a lot better with diabetes’, but 
also to a desire amongst his partners to ‘do more about preventing people becoming ill, 
rather than just reacting to the crises’.115 This began with opportunistic screening and 
following up care for patients with hypertension and non-insulin requiring diabetes 
during the 1970s and 1980s, but later took in individuals with conditions requiring 
similar long-term maintenance therapy, like hypothyroidism and epilepsy.  
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The notion that GPs should engage in preventive medicine was not new. 
Armstrong and Lewis, for instance, have pointed to similar claims on prevention during 
the early twentieth century, with Armstrong suggesting that engagement with 
epidemiology and social medicine resulted in an expanded surveillance ethos in general 
practice.116 However, in terms of proactive screening for disease, it seems that resource 
and knowledge limitations dissuaded many GPs from engaging in anything beyond 
opportunistic work during the early post-war decades.117 Furthermore, across the 1960s 
and early 1970s, some influential epidemiologists and public health doctors sought to 
link the detection and prevention of chronic diseases to the political future of the 
Medical Officer of Health (MOH).118 Politically, that is, GPs faced competition for 
space in preventive medicine, albeit within a context where collaboration was being 
encouraged from both academic and practitioner perspectives.119 After 1974, however, 
the role of the MOH had been abolished and public health doctors were incorporated as 
managers and service planners into the NHS as Community Physicians.120 GPs were 
thus afforded space to move into expanded preventive health work, including chronic 
disease management.121 In fact, work to improve service delivery and co-ordination in 
conditions like diabetes was even performed out of academic departments of 
community medicine and general practice, marking an institutional collaboration on 
public health from the old and new public health workers.122 
That managing non-insulin-dependent diabetes in general practice was included 
in considerations of preventive medicine is revealing. According to the GPs above, 
detecting disease early was no longer itself at the centre of discussions about disease 
prevention. Rather, in the context of patients being considered ‘at exceptional risk’ of 
arterial disease, managing diabetes patients more effectively - meaning proactive, 
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organised surveillance and therapeutic titration - had in itself become a core component 
of preventive medicine.123 The increasing centrality of epidemiological methods as 
clinical and public health tools was central to such a transformation. Uncovering large 
amounts of undetected and ‘subclinical’ disease, along with calculations of individual 
risk, cast prevention into three stages. Academic GPs and epidemiologists began to talk 
of primary prevention (preventing occurrence by treating a precursor state, targeting 
those at risk, or promoting health in the population), secondary prevention (preventing 
the progression of a subclinical disease into a clinical state by detecting asymptomatic 
cases and managing patients early), and tertiary prevention (preventing the worsening of 
a clinical condition into severe disability). Each stage was linked via a series of 
interconnected interventions.124 In light of such discussions, interlocutors claimed that 
the ‘poles of curative medicine on the one side and prevention on the other no longer 
apply’, broken down in suggested webs of risk and surveillance.125 As noted, given its 
serious complications and its status as a risk factor for other conditions, the detection 
and treatment of diabetes could be considered as secondary or tertiary prevention. 
Equally, targeting overweight or elderly individuals with preventive lifestyle advice as a 
means to avoid the condition could be classified as primary prevention.126 But it was 
this division between complete prevention, and the prevention of complications that 
turned diabetes management itself into a preventive health activity. It was a distinction 
that became sharper as acceptable – meaning more large-scale clinical and 
epidemiological – evidence emerged to buttress traditional faith in metabolic control as 
a deterrent to the emergence of diabetic complications.127 
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Conclusion 
Historians have long used the construction of, and responses to, specific diseases 
as lenses for investigating medicine and society.128 In this chapter, I have sought to 
connect changing understandings of a particular disease - diabetes mellitus - with 
shifting strategies and models of care as a means to draw out the drivers for service 
innovation in a period of broad epidemiological change. By focusing our gaze in this 
manner, it has been possible to demonstrate that clinical and organisational change in 
British chronic disease care was driven by more than shifting disease profiles and 
demographic patterns. Rather, a combination of financial constraints within a new 
health and welfare system, the deployment of novel diagnostic and surveillance 
technologies, changing meanings of disease and work, and fluctuating professional 
politics all shaped and helped generate a new model of care for long-term illness.  
Beyond this, however, a case study approach to disease management has also 
highlighted how responses to chronic disease care during the late twentieth century 
revolved around a process of bureaucratisation. In many respects, doctors and health 
care providers were building on a late-nineteenth and early-twentieth century heritage. 
As Steve Sturdy and Roger Cooter amongst others have noted, the development of mass 
health care provision - alongside concerns over population quality - generated a 
significant momentum for the bureaucratisation of medical care and knowledge at the 
turn of the century.129 Doctors, clinical researchers, insurance bodies and states alike 
converged over efforts to standardise diagnostic labels and processes, as well as to 
divide and reintegrate bodies (of knowledge, individuals, populations and medical 
labour) in pursuit of maximum efficiency.130 In post-war Britain, the need for efficiency 
grew ever more important under the resource-strapped NHS, whilst the integration of 
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clinical and epidemiological research cultures in elite institutions fostered 
understandings of care process as standardisable and reviewable.131 In terms of diabetes, 
these pressures extended beyond the initial hospital cocoon, following chronic disease 
care into general practice. Now spatially redistributed, medical teams drew on well-
developed bureaucratic cultures and practices in pursuit of more efficient and effective 
care: more tightly prescribing roles, documenting activity, and reviewing work than 
ever before within new hierarchies.132 This process was facilitated by an expanding 
range of tools for prescription and surveillance, as well as changing political projects in 
British general practice. 
These changes in diabetes care have had long-lasting legacies, despite research 
over the 1980s and early 1990s offering mixed results about their efficacy.133 In part, 
this is because models of diabetes management formed a symbolic part of broader 
arguments about raising standards in general practice into the 1980s and 1990s. By 
1985, for instance, diabetes had formed an early target for the RCGP’s `Quality 
Initiative’, and the College had begun discussing new models of care in terms of good 
general practice more broadly:134  
 
Teamwork and practice management are gaining recognition as essential rather 
than desirable for effective patient care in all types of practice, especially in the 
management of chronic diseases such as diabetes mellitus, hypertension and 
asthma, and in anticipatory care. Agreed protocols and standards, the registered 
list of patients, the continuous clinical record, the microcomputer, practice 
leaflets and the practice annual report are seen as some of the tools [central to 
such care].135 
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A discussion of the politics of this `quality’ agenda is beyond the scope of this 
chapter.136 Nonetheless, the equation of managed chronic disease care with good 
general practice underlined both the extent to which general practice was reforming 
around new sets of disease, and how far end-of-the-century visions of general practice 
had shifted away from earlier interest in facilities, practitioner intelligence and time 
management.137 Such has been the strength of this integration that the links between 
chronic disease care, bureaucratised managerialism and good general practice continue 
to the present day in contemporary discourse and policy. In 2004, for instance, the 
General Medical Services contract introduced the Quality and Outcomes Framework 
(QOF) for general practice, a voluntary pay-for-performance scheme to encourage 
improved organisation, expanded preventive health service delivery, and developed GP-
management of common chronic diseases. The QOF is vastly more complex than the 
earlier 1990s contracts, awarding gradated points for various levels of compliance with 
selected indicators. The premise of the scheme nonetheless shares much in common 
with the earlier contracts, and in particular with the emphases on bureaucracy, review, 
and GP chronic disease management.  Recent discussions of the QOF, whilst equivocal 
- and even critical - about its impact, have reinforced ideas that incentives are effective, 
and that organised GPs should provide vital preventive health care to local 
populations.138 
There is significant scope for further accounts of evolving architectures of care, 
as well as for more expansive discussions about how models of care and management 
moved between sites, specialties and conditions.139 Currently, for example, historians 
have paid very little attention to the histories of surveillance tools, and whilst the early-
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twentieth-century medical record has received significant attention, scholars have 
generally restricted their interest to this instrument.140 The histories of recall systems, of 
clinical computers, of care protocol, and clinical audit and guidelines – and, crucially, 
their connections to shifting understandings of disease, treatment and labour – are 
greatly under examined.141 Such studies are likely to take in significant changes in post-
war medicine, politics and society in specific (and interlinked) locations, and in the 
British case they will require closer attention to the interactions between private 
companies, public health care architectures, and large-scale research infrastructure than 
hitherto attempted.142 This work will undoubtedly prove challenging to historians, and 
require flexible, interdisciplinary frameworks for analysing disease and formations of 
medical labour. It will nonetheless likely also prove very valuable, and elucidate some 
of the defining features of post-war clinical practice.  
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